Cargando…

Using the Systemic Immune-Inflammation Index (SII) as a Mid-Treatment Marker for Survival among Patients with Stage-III Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

The Systemic Immune-Inflammation Index (SII) is an important marker of immune function, defined as the product of neutrophil-to-lymphocyte ratio (NLR) and platelet count (P). Higher baseline SII levels have been associated with improved survival in various types of cancers, including lung cancer. Da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biswas, Tithi, Kang, Kylie H., Gawdi, Rohin, Bajor, David, Machtay, Mitchell, Jindal, Charu, Efird, Jimmy T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662688/ https://www.ncbi.nlm.nih.gov/pubmed/33143164 http://dx.doi.org/10.3390/ijerph17217995

Ejemplares similares

Pretreatment neutrophil-to-lymphocyte ratio as an important prognostic marker in stage III locally advanced non-small cell lung cancer: confirmatory results from the PROCLAIM phase III clinical trial
por: Biswas, Tithi, et al.
Publicado: (2021)

A Pilot Study Examining the Prognostic Utility of Tumor Shrinkage on Cone-Beam Computed Tomography (CBCT) for Stage III Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Definitive Chemoradiation
por: Kang, Kylie H., et al.
Publicado: (2021)

On the Frontiers of Breast Cancer Diagnosis and Treatment: Current and Future Directions in a Rapidly Changing Field
por: Efird, Jimmy T., et al.
Publicado: (2022)

Cone beam computed tomography—the need for future guidance
por: Efird, Jimmy T., et al.
Publicado: (2022)

Dermatological Autoimmune Considerations of Immune Checkpoint Therapy
por: Fane, Lauren S., et al.
Publicado: (2022)

Pathologic Complete Response (pCR) and Survival of Women with Inflammatory Breast Cancer (IBC): An Analysis Based on Biologic Subtypes and Demographic Characteristics
por: Biswas, Tithi, et al.
Publicado: (2019)

The survival benefit of neoadjuvant chemotherapy and pCR among patients with advanced stage triple negative breast cancer
por: Biswas, Tithi, et al.
Publicado: (2017)

Breast Cancer Disparities in Asian Women: The Need for Disaggregated Research
por: Fane, Lauren, et al.
Publicado: (2022)

The Association between Age, Comorbidities and Use of Radiotherapy in Women with Breast Cancer: Implications for Survival
por: Efird, Jimmy T., et al.
Publicado: (2018)

Exercise reduces systemic immune inflammation index (SII) in childhood cancer patients
por: Winker, Matteo, et al.
Publicado: (2021)

Systemic immune-inflammation index, SII, for prognosis of elderly patients with newly diagnosed tumors
por: Li, Chan, et al.
Publicado: (2018)

Systemic Immune-Inflammation Index (SII) Predicts Increased Severity in Psoriasis and Psoriatic Arthritis
por: YORULMAZ, AHU, et al.
Publicado: (2020)

Association of systemic immune-inflammation index (SII) with presence of isolated coronary artery ectasia
por: Tosu, Aydın Rodi, et al.
Publicado: (2021)

Systemic Immune-Inflammation Index (SII) Correlates with Disease Severity in Hidradenitis Suppurativa Patients
por: Hayran, Yıldız, et al.
Publicado: (2023)

Systemic immune-inflammation index (SII): A More Promising Inflammation-Based Prognostic Marker for Patients with synchronic colorectal peritoneal carcinomatosis
por: Yan, Qian, et al.
Publicado: (2020)

Complications from Stereotactic Body Radiotherapy for Lung Cancer
por: Kang, Kylie H., et al.
Publicado: (2015)

Failure patterns and survival outcomes in triple negative breast cancer (TNBC): a 15 year comparison of 448 non-Hispanic black and white women
por: Prasad, Shreya, et al.
Publicado: (2016)

A Novel Inflammatory Marker in the Follow-up of Moderate-to-Severe Acne Vulgaris Administered Isotretinoin: Systemic Immune-Inflammation Index (SII)
por: TURAN, ÇAĞRI, et al.
Publicado: (2022)

Postoperative Systemic Immune-Inflammation Index (SII): A Superior Prognostic Factor of Endometrial Cancer
por: Huang, Yihong, et al.
Publicado: (2021)

Association between systemic immune-inflammation index (SII) and survival outcome in patients with primary glioblastoma
por: Yang, Chao, et al.
Publicado: (2023)

The association of hemodynamic markers of right ventricular dysfunction with SII index and clinical outcomes in reduced ejection fraction heart failure
por: Balci, Kevser, et al.
Publicado: (2023)

Using a Counting Process Method to Impute Censored Follow-Up Time Data
por: Efird, Jimmy T., et al.
Publicado: (2018)

Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection
por: Jomrich, Gerd, et al.
Publicado: (2019)

The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer
por: Bartl, Thomas, et al.
Publicado: (2020)

Adding Base-Excision Repair Inhibitor TRC102 to Standard Pemetrexed–Platinum–Radiation in Patients with Advanced Nonsquamous Non–Small Cell Lung Cancer: Results of a Phase I Trial
por: Biswas, Tithi, et al.
Publicado: (2022)

Race, insurance type, and stage of presentation among lung cancer patients
por: Efird, Jimmy T, et al.
Publicado: (2014)

Value of the Systemic Immune-Inflammatory Index (SII) in Predicting the Prognosis of Patients With Peripartum Cardiomyopathy
por: Zhang, Yuan, et al.
Publicado: (2022)

Preoperative Systemic Immune-Inflammation Index (SII) for Predicting the Survival of Patients with Stage I-III Gastric Cancer with a Signet-Ring Cell (SRC) Component
por: Zhu, Ziyu, et al.
Publicado: (2020)

Predictive value of systemic immune inflammation index (SII) and prognostic nutritional index (PNI) on mortality after below-knee amputation
por: Yilmaz, Selçuk, et al.
Publicado: (2023)

Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus
por: Feng, Ji-Feng, et al.
Publicado: (2017)

The role of systemic immune-inflammation index (SII) in the differential diagnosis of granulomatous and reactive LAP diagnosed by endobronchial ultrasonography
por: Kerget, Buğra, et al.
Publicado: (2023)

The Giant Adhesin SiiE of Salmonella enterica
por: Barlag, Britta, et al.
Publicado: (2015)

Exploring the Correlation Between the Systemic Immune Inflammation Index (SII), Systemic Inflammatory Response Index (SIRI), and Type 2 Diabetic Retinopathy
por: Wang, Shuqi, et al.
Publicado: (2023)

Prognostic impact of elevated pre-treatment systemic immune-inflammation index (SII) in hepatocellular carcinoma: A meta-analysis
por: Wang, Bolin, et al.
Publicado: (2020)

Prognostic Significance of the Systemic Immune-Inflammation Index (SII) in Patients With Small Cell Lung Cancer: A Meta-Analysis
por: Zhou, Yuting, et al.
Publicado: (2022)

Systemic Immune-Inflammation Index (SII) Can Be an Early Indicator for Predicting the Severity of Acute Pancreatitis: A Retrospective Study
por: Liu, Xingming, et al.
Publicado: (2021)

Association of the systemic immune-inflammation index (SII) and clinical outcomes in patients with stroke: A systematic review and meta-analysis
por: Huang, Yong-Wei, et al.
Publicado: (2022)

High Neutrophil-To-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) Are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of Rectal Cancer
por: Polk, Nándor, et al.
Publicado: (2022)

Predictive Value of the Platelet Times Neutrophil-to-Lymphocyte Ratio (SII Index) for COVID-19 In-Hospital Mortality
por: Ballaz, Santiago J., et al.
Publicado: (2023)

The Value of SII in Predicting the Mortality of Patients with Heart Failure
por: Yuan, Miao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2op850ah2hb69lg04lfteg07ff